Attention Deficit Hyperactivity Disorder Adhd — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for attention deficit hyperactivity disorder adhd . 12 active patents protecting 1 drugs from 0+ originators. First major cliff: 2033. Daily refresh.

1
Approved drugs
12
Active US patents
57/100
Avg vulnerability
Annual revenue covered

Originators in Attention Deficit Hyperactivity Disorder Adhd

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating attention deficit hyperactivity disorder adhd . Each bar = one year. Y-axis scaled to peak year (8 patents).

8
33

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
DEXTROAMPHETAMINE 12 57 2033-10-24

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
11559501 DEXTROAMPHETAMINE formulation 50 2042-01-06
11559501 DEXTROAMPHETAMINE formulation 50 2042-01-06

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11559501 DEXTROAMPHETAMINE formulation 50 2042-01-06
11559501 DEXTROAMPHETAMINE formulation 50 2042-01-06
11559501 DEXTROAMPHETAMINE formulation 50 2042-01-06
11559501 DEXTROAMPHETAMINE formulation 50 2042-01-06
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
9474722 DEXTROAMPHETAMINE formulation 50 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24
9456993 DEXTROAMPHETAMINE method of use 70 2033-10-24

Related